Protein fragment discovery could avoid need for CT/MRI
This article was originally published in Clinica
US researchers have identified a nerve cell protein called NF-H that may help doctors more quickly and precisely treat people with severe head injury or brain disease. The discovery could ultimately lead to a clinical test for diagnosing such ailments from just a few drops of blood, rather than cumbersome and expensive CT or MRI brain scanning equipment.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.